We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$6.97B
AUM Growth
+$4.79B
(+220%)
Cap. Flow
+$6.91B
Cap. Flow
% of AUM
99.25%
Top 10 Holdings %
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,371
Increased
1,984
Reduced
143
Closed
794
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 100 ETF
OEF
|
+$2.43B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.24B |
| 3 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$202M |
| 4 |
American Century Diversified Corporate Bond ETF
KORP
|
+$152M |
| 5 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$91.2M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$62.6M |
| 3 |
AXON
Axon Enterprise
AXON
|
+$58.1M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$46.5M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.48% |
| 2 | Financials | 8.05% |
| 3 | Industrials | 7.03% |
| 4 | Consumer Discretionary | 6.62% |
| 5 | Healthcare | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
ArriVent BioPharma
AVBP
$1.44B
| $5.31K | ﹤0.01% |
+288
| New | +$5.66K |
|
2852
BlackRock Debt Strategies Fund
DSU
$597M
| $5.31K | ﹤0.01% |
+500
| New | +$5.28K |
|
|
AKRO
2853
DELISTED
Akero Therapeutics
AKRO
| $5.27K | ﹤0.01% |
+111
| New | +$5.38K |
|
|
AFCG
2854
AFC Gamma
AFCG
$63.4M
| $5.25K | ﹤0.01% |
1,371
+942
| +220% | +$4.18K |
|
|
NB
2855
NioCorp Developments
NB
$780M
| $5.24K | ﹤0.01% |
785
+220
| +39% | +$928 |
|
2856
Iridium Communications
IRDM
$5.29B
| $5.2K | ﹤0.01% |
298
+258
| +645% | +$6.38K |
|
2857
KRONOS Worldwide
KRO
$989M
| $5.2K | ﹤0.01% |
+905
| New | +$5.48K |
|
2858
Clarivate
CLVT
$1.16B
| $5.19K | ﹤0.01% |
1,355
+55
| +4% | +$231 |
|
2859
TeraWulf
WULF
$8.52B
| $5.18K | ﹤0.01% |
+454
| New | +$3.47K |
|
2860
The RealReal
REAL
$1.48B
| $5.16K | ﹤0.01% |
+485
| New | +$3.59K |
|
2861
WIX.com
WIX
$2.52B
| $5.15K | ﹤0.01% |
+29
| New | +$4.36K |
|
2862
DMC Global
BOOM
$157M
| $5.15K | ﹤0.01% |
+609
| New | +$4.56K |
|
2863
Burford Capital
BUR
$968M
| $5.14K | ﹤0.01% |
+430
| New | +$5.75K |
|
|
PAMT
2864
PAMT Corp
PAMT
$297M
| $5.14K | ﹤0.01% |
+451
| New | +$5.74K |
|
2865
AtriCure
ATRC
$2.11B
| $5.11K | ﹤0.01% |
145
+127
| +706% | +$4.38K |
|
2866
TFI International
TFII
$11.5B
| $5.11K | ﹤0.01% |
58
+48
| +480% | +$4.39K |
|
2867
Mid Penn Bancorp
MPB
$952M
| $5.1K | ﹤0.01% |
178
+148
| +493% | +$4.31K |
|
|
BLFY
2868
DELISTED
Blue Foundry Bancorp
BLFY
| $5.02K | ﹤0.01% |
552
+526
| +2,023% | +$4.83K |
|
2869
Simulations Plus
SLP
$371M
| $5K | ﹤0.01% |
+332
| New | +$4.83K |
|
2870
Rayonier Advanced Materials
RYAM
$610M
| $5K | ﹤0.01% |
+692
| New | +$3.56K |
|
2871
Descartes Systems
DSGX
$6.82B
| $4.99K | ﹤0.01% |
53
+45
| +563% | +$4.6K |
|
|
HTD
2872
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$900M
| $4.98K | ﹤0.01% |
+201
| New | +$4.89K |
|
2873
GeneDx Holdings
WGS
$2.3B
| $4.96K | ﹤0.01% |
+46
| New | +$5.01K |
|
|
NPB
2874
Northpointe Bancshares
NPB
$592M
| $4.95K | ﹤0.01% |
+290
| New | +$4.74K |
|
2875
NewAmsterdam Pharma
NAMS
$3.34B
| $4.95K | ﹤0.01% |
+174
| New | +$4.17K |
|
Similar funds
TYCC
TH
BCP
WWA
VPC
BPS
TCM
DILIC
Arax Advisory Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,371 new positions and adding to 1,984 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.
- Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
- Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
- Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
- Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
- Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
- Arax Advisory Partners opened 1,371 new positions and closed 794 in Q3 2025.
- Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.
Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.